Who "Controls" The Drug Companies?
So, who really controls the major drug companies and distributors,
according to market cap. When you start to see that the same "owners" show up in
hospital companies, it's no wonder that we can not
afford to pay our medical bills. Perhaps this is why we can't even get help from our
representatives to Congress: [and this is only from the top 20 list.]
|American Medical Assn||$19,380,000||Pharmaceutical Rsrch & Mfrs of America||$16,517,781
||American Hospital Assn||$16,405,186
||Blue Cross/Blue Shield (Wellpoint)||$ 8,903,590
||Medical Lobbying Total for 2005||$61,206,557
No wonder politicians don't care about how much it costs to run for their office.
Healthcare might just be only one avenue by which public affairs is used for private gain.
Another interesting fact is that of the eight companies listed, 32 key executives take out
a total of $70.41M PER YEAR! No wonder pills cost so much.
I can't help but think that nothing
has really changed since 1889, when the Great Red Dragon book was published,
except that a greater amount of power has been concentrated into fewer hands since then,
at significant costs to all of us.
In fact, on October 6, 2006, in the Wall Street Journal, there was a front page article
specifically about how "Middlemen Strike It Rich." Yeah, and at our expense. It was as
simple as broad revisions to a key published list. Read the story:
How Quiet Moves By A Publisher Sway Billions In Drug Spending.
The point is, control of American companies is rapidly being consolidated
into a few foreign hands, and they are also doing so at
Damn any of the promises that had been made, such as retirement benefits,
health care and pensions. And why is this being done?
To "own the earth in fee simple."
You can do the same lookup on any public corporation and see for yourself who controls what.
You will also see that some of the major holders are hardly nothing more than
a "front" for another, more powerful group. Simply find out who the major holders
of the major holders are and you will see for yourself. This is simply
to make it easier to deceive the public.
While doing this, remember that it only takes 10%, sometime less, sometimes more,
of the stock to "control" a widely-held corporation.
Especially when management and insiders show little or zero ownership. They, as hirelings,
simply take their marching orders and their large paychecks, and everybody else be damned.
If they show any conscience about what happens to their employees or customer base,
they are simply replaced by another "aggressive leader."
Be sure to click on the company's stock letters to check on these
"Key Executives," the sums they were paid last year, and the stock options they cashed.
Another problem we're facing now is the growth of private-equity
groups, which don't have to make the same disclosures as the publicly-held groups.
This is why they keep gaining up on the SEC to "prevent" disclosure and accountability.
This story appeared September 1, 2006:
Buyout Firms Join Lobbying Efforts.
I have no illusions that they are simply another type of
"Snakes In Suits."
One last thing: If you found this information valuable,
please help support this site.
With that being said, here goes:
||Name Of Corporation
|1. Pfizer Inc. [$207.59B] (acquired
Searle in 2003)
|Barclays Global Investors UK Holdings Ltd||4.48%||State Street Corporation||3.06%
||Vanguard Group, Inc.||2.58%
||Franklin Resources, Inc.||1.90%
||AXA (Paris, France)||1.83%
||Dodge & Cox Inc.||1.75%
||FMR Corporation (Fidelity Management & Research Corp)||1.52%
||Deutsche Bank Aktiengesellschaft||1.51%
||Legg Mason Inc.||1.50%
||Capital Research And Management Company||1.36%
||Top 10 of 1477 Institutional Holders Control||21.49%
||Barclays and "Associates" Control||10.94%
|2. Johnson & Johnson [$187.76B]
|3. Glaxosmithkline plc [$152.67B]
|% of Shares Held by US Institutional & Mutual Fund Owners:||10.00%||% of Float Held by US Institutional & Mutual Fund Owners:||10.00%
||Company is headquartered in Brentford, the United Kingdom..
||Company's mailing address is Brentford, the United Kingdom..
||Barclays probably owns controlling interest in Glaxosmithkline plc.
|4. Novartis AG [$122.13B]
|% of Shares Held by US Institutional & Mutual Fund Owners:||3.00%||% of Float Held by US Institutional & Mutual Fund Owners:||3.00%
||Company is headquartered in Basel, Switzerland.
||Company's mailing address is Basel, Switzerland.
|5. AstraZeneca plc [$99.57B]
|% of Shares Held by US Institutional & Mutual Fund Owners:||8.00%||% of Float Held by US Institutional & Mutual Fund Owners:||8.00%
||Company is headquartered in London, the United Kingdom.
||Company's mailing address is London, the United Kingdom.
||Barclays probably owns controlling interest in AstraZeneca plc.
|6. Merck & Co. Inc. [$91.27B]
|Capital Research And Management Company||5.60%||Barclays Global Investors UK Holdings Ltd||4.40%
||State Street Corporation||3.37%
||Franklin Resources, Inc.||3.35%
||AXA (Paris, France)||3.08%
||FMR Corporation (Fidelity Management & Research Corp)||2.72%
||Vanguard Group, Inc.||2.60%
||Deutsche Bank Aktiengesellschaft||1.87%
||Brandes Investment Partners L.P.||1.87%
||Mellon Financial Corporation||1.63%
||Top 10 of 1047 Institutional Holders Control||30.49%
||Barclays and "Associates" Control||12.75%
|7. Abbott Laboratories [$73.69B]
|8. Wyeth [$68.12B]
|FMR Corporation (Fidelity Management & Research Corp)||5.72%||Barclays Global Investors UK Holdings Ltd||4.06%
||Wellington Management Company, LLP||3.86%
||UBS Global Asset Management||2.88%
||State Street Corporation||2.59%
||Vanguard Group, Inc.||2.55%
||Capital Research And Management Company||2.07%
||Lord Abbett & Co.||2.04%
||JP Morgan Chase & Company||1.76%
||Top 10 of 1088 Institutional Holders Control||29.75%
||Barclays and "Associates" Control||10.94%
|9. Eli Lilly & Co. [$63.74B]
|Lilly Endowment, Inc.||12.72%||Capital Research And Management Company||8.85%
||Wellington Management Company, LLP||5.88%
||Barclays Global Investors UK Holdings Ltd||2.98%
||State Street Corporation||2.52%
||Vanguard Group, Inc.||2.49%
||Primecap Management Company||2.49%
||AXA (Paris, France)||2.48%
||State Farm Mutual Automobile Insurance Co||1.78%
||Top 10 of 861 Institutional Holders Control||43.48%
||Barclays and "Associates" Control||6.79%
|10. Bristol-Myers Squibb Co. [$48.77B]
|Capital Research And Management Company||10.93%||Morgan Stanley||4.51%
||Bank Of America Corporation||3.65%
||Barclays Global Investors UK Holdings Ltd||3.36%
||Franklin Resources, Inc.||3.04%
||Wellington Management Company, LLP||2.78%
||Brandes Investment Partners L.P.||2.73%
||Vanguard Group, Inc.||2.58%
||State Street Corporation||2.57%
||Barrow, Hanley Mewhinney & Strauss, Inc.||2.45%
||Top 10 of 918 Institutional Holders Control||39.60%
||Barclays and "Associates" Control||17.13%
|11. McKesson Corp. (Drug Wholesaler) [$15.20B]
|Wellington Management Company, LLP||11.92%||Capital Research And Management Company||5.54%
||Goldman Sachs Group Inc||4.64%
||State Street Corporation||4.02%
||Legg Mason Inc.||3.36%
||Barclays Global Investors UK Holdings Ltd||3.33%
||Vanguard Group, Inc.||2.61%
||Glenview Capital Management, LLC||2.48%
||FMR Corporation (Fidelity Management & Research Corp)||2.43%
||Janus Capital Management, LLC||1.63%
||Top 10 of 429 Institutional Holders Control||41.96%
||Barclays and "Associates" Control||15.35%
© 2006 by Edward Ulysses Cate
Help Support This Site